Myungmoon Pharma. Co. Ltd.
2 clinical trials · Sponsor
◉ Watch Myungmoon Pharma. Co. Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Efficacy and Safety of CnU Cap. 500 mg in Patients With Biliary Dyspepsia (NCT07016269) | Myungmoon Pharma. Co. Ltd. | 2025-08-29 |
| A Study to Evaluate the Efficacy and Safety of CnU Capsule 750 mg in Patients With Cholesterol Gallstones(GB Stones). (NCT07005752) | Myungmoon Pharma. Co. Ltd. | 2025-07-28 |
Track Myungmoon Pharma. Co. Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.